From October 22 to 24, tongfreehand’s 110th activity “the fifth Chengdu biomedical innovation and Development Conference”, the thousand people’s Congress came with heavy weight!
The conference has a main venue and six sub venues to exchange views on chemical drug research and development, new biological technology drug research and development, clinical research and development, and Drug Administration and regulations.
All the leading enterprises in the industry will participate in the exhibition!
become
Chengdu shengnuo biopharmaceutical Co., Ltd
Booth No.: B07
Innovative polypeptide drugs one stop cdmo service platform
Chengdu shengnuo biopharmaceutical Co., Ltd. focuses on peptide drugs, undertakes cdmo services for innovative polypeptide projects at home and abroad, and has an independent R & D team to accelerate the process of new drug research and development of enterprises and R & D institutions.
Helping China's new drug research and development move towards the international arena